Dyspnea and asthma

Current Opinion in Pulmonary Medicine

Volumn 12, Issue 1, 2006, Pages 18-22

  Scano, Giorgio ^a   Stendardi, Loredana ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Bronchodilation; Perception of bronchoconstriction; Quality of life; Respiratory function

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; FLUTICASONE; FORMOTEROL; LEUKOTRIENE RECEPTOR BLOCKING AGENT; SALBUTAMOL; SALMETEROL; ZAFIRLUKAST;

AIRWAY OBSTRUCTION; ASTHMA; BRONCHOSPASM; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DRUG RESPONSE; DYSPNEA; EXERCISE; FORCED EXPIRATORY VOLUME; GENERAL CONDITION IMPROVEMENT; HUMAN; HYPERINFLATION; HYPOXIA; NEUROIMAGING; PATHOGENESIS; PATHOPHYSIOLOGY; PERCEPTION; RESPIRATORY FUNCTION; REVIEW; RISK FACTOR; SCORING SYSTEM; SYMPTOM; AIRWAY RESISTANCE; BREATHING MECHANICS; PHYSIOLOGY; QUALITY OF LIFE; SENSATION;

AIRWAY RESISTANCE; ASTHMA; BRONCHOCONSTRICTION; BRONCHODILATOR AGENTS; DYSPNEA; HUMANS; PERCEPTION; QUALITY OF LIFE; RESPIRATORY MECHANICS; SENSATION;

EID: 33646849871     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/01.mcp.0000199003.46038.82     Document Type: Review

References (35)

1. Peiffer C, Poline J, Thivard L, et al. Neural substrates for the perception of acutely induced dyspnea. Am J Respir Crit Care Med 2001; 163:951-957.
2. Moy ML, Woodrow Weiss J, Sparrow D, et al. Quality of dyspnoea in bronchoconstriction differs from external resistive loads. Am J Respir Crit Care Med 2000; 162:451-455.
3. Lougheed MD, Lam M, Forkert L, et al. Breathlessness during acute bronchoconstriction in asthma. Am Rev Respir Dis 1993; 148:452-459.
4. Ottanelli R, Rosi E, Romagnoli I, et al. Perception of bronchoconstriction and bronchial hyperresponsiveness in asthma. Clin Sci 2000; 98:681-687.
5. Ottanelli R, Rosi E, Romagnoli I, et al. Do inhaled corticosteroids affect perception of dyspnea during bronchoconstriction in asthma? Chest 2001; 120:770-777.
6. Killian KJ, Watson R, Otis J, et al. Symptom perception during acute bronchoconstriction. Am J Respir Crit Care Med 2000; 162:490-496.
7. Gorini M, Iandelli I, Misuri G, et al. Chest wall hyperinflation during acute bronchoconstriction in asthma. Am J Respir Crit Care Med 1999; 160:808-816.
8. Filippelli M, Duranti R, Gigliotti F, et al. Overall contribution of chest wall hyperinflation to breathlessness in asthma. Chest 2003; 124:2164-2170.
9. Scano G, Stendardi L, Grazzini M. Understanding dyspnea by its language. Eur Respir J 2005; 25:380-385. This paper analyses the relationships between dyspnea descriptors and the underlying pathophysiologic mechanisms.
10. Stendardi L, Grazzini M, Gigliotti F, et al. Dyspnea and leg effort during exercise. Respir Med 2005; 99:933-942. This paper overviews the mechanisms underlying exercise dyspnea in asthma.
11. Moy ML, Lantin ML, Harver A, et al. Language of dyspnea in assessment of patients with acute asthma treated with nebulized albuterol. Am J Respir Crit Care Med 1998; 158:749-753.
12. McFadden ER Jr. Acute severe asthma. Am J Respir Crit Care Med 2003; 168:740-759.
13. Liberatos P, Link BG, Kelsey JL. The measurement of social class in epidemiology. Epidemiol Rev 1988; 10:87-121.
14. Weitzman M, Gortmaker S, Sobol A. Racial, social and environmental risks for childhood asthma. Am J Dis Child 1990; 144:1189-1194.
15. Woolcock AJ, Peat JK. Evidence for increase in asthma worldwide. Ciba Found Symp 1997; 206:122-139.
16. von Leupold A, Dahme B. Cortical substrates for the perception of dyspnea. Chest 2005; 128:345-354.
17. Suman O, Babcock MA, Pegelow DF, et al. Airway obstruction during exercise in asthma. Am J Respir Crit Care Med 1995; 152:23-31.
18. Barreiro E, Gea J, Sanjuas C, et al. Dyspnoea at rest and at the end of different exercises in patients with near-fatal asthma. Eur Respir J 2004; 24:219-225. This paper contributes to explaining the blunted perception of dyspnea in patients with near fatal asthma.
19. Abou-Hasam M, Tannouis B, Weimberger M. Exercise-induced dyspnea in children and adolescent: if not asthma then what? Ann Allergy Asthma Immunol 2005; 94:366-371.
20. Eckert DJ, Catcheside PG, McEvoy RD. Blunted sensation of dyspnea and near fatal asthma. Eur Respir J 2004; 24:197-199.
21. Eckert DJ, Catcheside PG, Smith JH, et al. Hypoxia suppresses symptom perception in asthma. Am J Respir Crit Care Med 2004; 169:124-130. This paper provides evidence of the role of hypoxia as a contributing factor to the reduced perception of dyspnea in asthma.
22. Morris KF, Gozas D. Persistent respiratory changes following intermittent hypoxic stimulation in cats and human beings. Respir Physiol 2004; 14:1-8.
23. Varraso R, Siroux V, Maccario J, et al. Asthma severity is associated with body mass index and early menarche in women. Am J Respir Crit Care Med 2005; 171:334-339. This paper provides evidence that BMI independently contributes to dyspnea. Moreover, the part of dyspnea not related to BMI is considered a proxy for decreased physical activity.
24. Sontag SJ, O'Connel S, Miller TQ, Bernsen M. Asthmatics have more nocturnal gasping and reflux symptoms than nonasthmatics, and they are related to bedtime eating. Am J Gastroenterol 2004; 99:789-796. The paper shows that compared with individuals without asthma, those with asthma have more GER symptoms and more pulmonary symptoms, particularly suffocation. This study contributes to clarifying the poorly understood link between asthma and GER.
25. Van der Woude HJ, Postma DS, Politiek MJ, et al. Relief of dyspnoea by b2-agonists after methacholine-induced bronchoconstriction. Respir Med 2004; 98:816-820.
26. Silverman RA, Nowak RM, Korenblat PE, et al. Zafirlukast treatment for acute asthma: evaluation in randomized, double-blind multicenter trial. Chest 2004; 126:1480-1489. This study reports on a multicenter trial examining the effect of leukotriene receptor antagonist on asthma symptom relapse after an acute asthma episode.
27. Donohue JF. Therapeutic responses in asthma and COPD. Bronchodilators Chest 2004; 126:125s-137s.
28. De Swert LF, Wouters C, de Zegher F. Myopathy in children receiving highdose inhaled fluticasone. New Eng J Med 2004; 350:1157-1159.
29. Mommers M, Gielkens-Sijstermans C, Swaen GMH, van Schayck CP. Trends in the prevalence of respiratory symptoms and treatment in Dutch children over a 12 year period: results of the fourth consecutive survey. Thorax 2005; 60:97-99. An important paper on the role of the rising prevalence of medication use as a potential factor explaining the concurrent decrease in the prevalence of asthma symptoms.
30. Eagan TML, Gulsvik A, Eide GE, Bakke PS. The effect of educational level on the incidence of asthma and respiratory symptoms. Respir Med 2004; 98:730-736. This study contributes to clarifying the effects of socialeconomic status on the incidence of adult asthma.
31. Snyder LD, Eisner MD. Obstructive lung disease among the urban homeless. Chest 2004; 125:1719-1725. This is an interesting study focusing on one important and possible unmet need among this segment of the population.
32. Dimich-Ward H, Lee Wymer M, Chan-Yeung MB. Respiratory health survey of respiratory therapists. Chest 2004; 126:1048-1053.
33. Juniper EF, Wisniewski ME, Cox FM, et al. Relationship between quality of life and clinical status in asthma: a factor analysis. Eur Respir J 2004; 23:287-291. An important study stressing the independence of QoL as an instrument to evaluate the condition of chronic stable asthma.
34. Nishimura K, Hajiro T, Oga T, et al. A comparison of two simple measures to evaluate the Health Status of asthmatics: the Asthma Bother Profile and the Airways Questionnaire 20. J Asthma 2004; 41:141-146.
35. Ambrosino N, Scano G. Dyspnoea and its measurement. Breathe 2004; 1:101-107. This paper describes some of the methods available for the measurement of dyspnea.